<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Transplant.</journal-id>
<journal-title>Frontiers in Transplantation</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Transplant.</abbrev-journal-title>
<issn pub-type="epub">2813-2440</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/frtra.2024.1260125</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Transplantation</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>A minor tweak in transplant surgery protocols alters the cellular landscape of the arterial wall during transplant vasculopathy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Mickiewicz</surname><given-names>Laura</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/2611293/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Zahreddine</surname><given-names>Rana</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/1482290/overview" />
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib>
<contrib contrib-type="author"><name><surname>Cormier</surname><given-names>K&#x00E9;vin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Peries</surname><given-names>Sophie</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib>
<contrib contrib-type="author"><name><surname>Del Bello</surname><given-names>Arnaud</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/803254/overview" />
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Laffargue</surname><given-names>Muriel</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/776247/overview" />
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Smirnova</surname><given-names>Natalia F.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/2210160/overview" />
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><institution>Institute of Metabolic and Cardiovascular Diseases (I2MC), Institut National de la Sant&#x00E9; et de la Recherche M&#x00E9;dicale (INSERM) U1297, University of Toulouse 3</institution>, <addr-line>Toulouse</addr-line>, <country>France</country></aff>
<aff id="aff2"><label><sup>2</sup></label><institution>CREFRE-Anexplo, Services Ph&#x00E9;notypage et Microchirurgie, UMS006, INSERM, Universit&#x00E9; de Toulouse, UT3, ENVT</institution>, <addr-line>Toulouse</addr-line>, <country>France</country></aff>
<aff id="aff3"><label><sup>3</sup></label><institution>Center for Biological Ressources (Centres de Ressources Biologiques, CRB), IUCT Oncopole, Toulouse University Hospital (CHU de Toulouse)</institution>, <addr-line>Toulouse</addr-line>, <country>France</country></aff>
<aff id="aff4"><label><sup>4</sup></label><institution>Department of Nephrology and Organ Transplantation, Toulouse University Hospital (CHU de Toulouse)</institution>, <addr-line>Toulouse</addr-line>, <country>France</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> Alessandro Alessandrini, Massachusetts General Hospital and Harvard Medical School, United States</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Jane O, Massachusetts General Hospital and Harvard Medical School, United States</p>
<p>Johannes Wedel, Boston Children&#x2019;s Hospital, United States</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Natalia F. Smirnova <email>natalia.smirnova@inserm.fr</email></corresp>
</author-notes>
<pub-date pub-type="epub"><day>29</day><month>04</month><year>2024</year></pub-date>
<pub-date pub-type="collection"><year>2024</year></pub-date>
<volume>3</volume><elocation-id>1260125</elocation-id>
<history>
<date date-type="received"><day>17</day><month>07</month><year>2023</year></date>
<date date-type="accepted"><day>02</day><month>04</month><year>2024</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2024 Mickiewicz, Zahreddine, Cormier, Peries, Del Bello, Laffargue and Smirnova.</copyright-statement>
<copyright-year>2024</copyright-year><copyright-holder>Mickiewicz, Zahreddine, Cormier, Peries, Del Bello, Laffargue and Smirnova</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><sec><title>Introduction</title>
<p>Transplant vasculopathy (TV) is a major complication after solid organ transplantation, distinguished by an arterial intimal thickening that obstructs the vascular lumen and leads to organ rejection. To date, TV remains largely untreatable, mainly because the processes involved in its development remain unclear. Aortic transplantation in mice, used to mimic TV, relies on highly variable experimental protocols, particularly regarding the type of anastomosis used to connect the donor aorta to the recipient. While the amount of trauma undergone by a vessel can dramatically affect the resulting pathology, the impact of the type of anastomosis on TV in mice has not been investigated in detail.</p>
</sec><sec><title>Methods</title>
<p>In this study, we compare the cellular composition of aortic grafts from BALB/C donor mice transplanted into C57BL/6J recipient mice using two different anastomosis strategies: sleeve and cuff.</p>
</sec><sec><title>Results</title>
<p>While both models recapitulated some aspects of human TV, there were striking differences in the cellular composition of the grafts. Indeed, aortic grafts from the cuff group displayed a larger coverage of the neointimal area by vascular smooth muscle cells compared to the sleeve group. Aortic grafts from the sleeve group contained higher amounts of T cells, while the cuff group displayed larger B-cell infiltrates.</p>
</sec><sec><title>Discussion</title>
<p>Together, these data indicate that a seemingly minor technical difference in transplant surgery protocols can largely impact the cellular composition of the graft, and thus the mechanisms underlying TV after aortic transplantation in mice.</p>
</sec>
</abstract>
<kwd-group>
<kwd>transplantation</kwd>
<kwd>surgery</kwd>
<kwd>anastomosis</kwd>
<kwd>vascular wall</kwd>
<kwd>transplant vasculopathy</kwd>
</kwd-group><contract-num rid="cn001">ANR-22-CE14-0012</contract-num><contract-num rid="cn002">PME202106013863</contract-num><contract-sponsor id="cn001">Agence Nationale de la Recherche</contract-sponsor><contract-sponsor id="cn002">Fondation pour la Recherche M&#x00E9;dicale</contract-sponsor><counts>
<fig-count count="5"/>
<table-count count="1"/><equation-count count="0"/><ref-count count="50"/><page-count count="0"/><word-count count="0"/></counts><custom-meta-wrap><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Transplantation Immunology</meta-value></custom-meta></custom-meta-wrap>
</article-meta>
</front>
<body><sec id="s1" sec-type="intro"><label>1</label><title>Introduction</title>
<p>Solid organ transplantation represents the best, if not the only option available for patients with end-stage organ failure (kidney, heart, lung, etc.). With the aging of the population, the number of transplant procedures and of patients on the waiting list for a transplant is steadily increasing (<xref ref-type="bibr" rid="B1">1</xref>). While the continuous improvement of immunosuppressive therapies tremendously reduced the rates of acute rejection, chronic rejection, affecting the grafts months or years post-transplant, remains a leading medical challenge (<xref ref-type="bibr" rid="B2">2</xref>). Chronic rejection encompasses a set of phenotypes (<xref ref-type="bibr" rid="B3">3</xref>), among which transplant vasculopathy (TV), associated with poor prognosis and largely untreatable (<xref ref-type="bibr" rid="B4">4</xref>&#x2013;<xref ref-type="bibr" rid="B6">6</xref>).</p>
<p>TV affects the entire arterial tree of a graft, encompassing big arteries and terminal arterioles. TV histologically resembles restenosis, as it displays an obliteration of the vascular lumen, due to the formation of a neointima (NI) rich in vascular smooth muscle cells (VSMCs) (<xref ref-type="bibr" rid="B7">7</xref>). Studies on restenosis and atherosclerosis show that neointimal VSMCs derive from dedifferentiated medial VSMCs, which acquire abnormal capacities of migration and proliferation inside the vascular lumen (<xref ref-type="bibr" rid="B8">8</xref>). Fewer reports are available on the cellular composition of arteries affected by TV in humans. The existing data show the presence of VSMCs but also recruited cells inside the neointima in the context of TV (<xref ref-type="bibr" rid="B9">9</xref>&#x2013;<xref ref-type="bibr" rid="B11">11</xref>).</p>
<p>In an attempt to understand the processes underlying TV, aortic transplantation in mice is a commonly used strategy. Yet it relies on multiple experimental variations throughout the literature: (1) both thoracic and abdominal aortas are used as donor organs (<xref ref-type="bibr" rid="B12">12</xref>); (2) they are connected either to the abdominal aorta or the carotid artery of the recipient (<xref ref-type="bibr" rid="B13">13</xref>); and (3) they use either sleeve (<xref ref-type="bibr" rid="B12">12</xref>), cuff-based (<xref ref-type="bibr" rid="B13">13</xref>), or end-to-end anastomosis. Mostly, BALB/C and C57BL/6J (B6) mice are used as donors and recipients, respectively, and sometimes in other combinations, such as male donors and female recipients. In the majority of cases, no immunosuppression is applied, generating a phenotype partially based on acute cellular rejection.</p>
<p>The combination of these multiple techniques raises the question of the comparability of the data generated. For example, the mechanisms underlying intimal hyperplasia are largely impacted by the severity of the injury (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>), which can in turn be affected by the type of anastomosis. While one study showed that intimal hyperplasia rates were independent of the type of anastomosis in mice (<xref ref-type="bibr" rid="B15">15</xref>), the influence of the type of anastomosis on the cellular composition of the murine aortic graft is so far unexplored.</p>
<p>To address this question, we provide a comparative report of the cellular distribution within murine aortic grafts connected using cuff and sleeve anastomosis strategies. Our data reveal the deep impact of the type of anastomosis on the cellular structure of the graft, both in terms of structure and immune cell infiltration.</p>
</sec>
<sec id="s2"><label>2</label><title>Material and methods</title>
<sec id="s2a"><label>2.1</label><title>Aortic transplantation in mice</title>
<p>In this study, BALB/C mice were used as donors and C57BL/6J as recipients. All mice were male, aged 8&#x2013;12 weeks at the time of transplant, and purchased from ENVIGO RMS SARL (Harlan Laboratories, Gannat, France). The mice were housed at the animal facility (zootechnie de Rangueil, CREFRE, INSERM US006) under SPF conditions, at a regulated temperature (20&#x2009;&#x00B0;C), with free access to food and water. Five donor mice and five recipient mice were used in each group for transplant surgeries. The surgical procedures are illustrated in <xref ref-type="fig" rid="F1">Figure&#x00A0;1A</xref>.</p>
<fig id="F1" position="float"><label>Figure 1</label>
<caption><p>Induction of transplant vasculopathy after aortic transplantation in mice using the sleeve and cuff anastomosis methods. C57BL/6J recipient mice were orthotopically transplanted with abdominal aortas from BALB/C donor mice, using either the sleeve or the cuff anastomosis method and were analyzed at 1 and 2 months after transplantation (1 month: sleeve group <italic>n</italic>&#x2009;&#x003D;&#x2009;5, cuff group <italic>n</italic>&#x2009;&#x003D;&#x2009;5; 2 months: sleeve group, <italic>n</italic>&#x2009;&#x003D;&#x2009;5; cuff group: <italic>n</italic>&#x2009;&#x003D;&#x2009;5). (<bold>A</bold>) Schematic representation of the sleeve and cuff anastomosis methods and photomicrographs of the implantation into the recipient. (<bold>B</bold>) Experimental protocol time-line. Schematic representation of the histological analysis of the aortic grafts: 5 &#x00B5;m-thick cross-sections are cut every 100&#x2005;&#x00B5;m along the aortic graft. (<bold>C</bold>) Representative images of histological cross-sections of aortic grafts from indicated groups and time-points stained with Masson Trichrome. Scale bar&#x2009;&#x003D;&#x2009;100&#x2005;&#x00B5;m. Quantification of transplant vasculopathy using the neointima/media ratio in indicated zones of the graft. Data are represented as mean&#x2009;&#x00B1;&#x2009;SEM and compared with Mann&#x2013;Whitney test. &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05; &#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01. (<bold>D</bold>) Average neointima/media ratio in the whole graft, regardless of the zones. Data are represented as mean&#x2009;&#x00B1;&#x2009;SEM and compared with Mann-Whitney test.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="frtra-03-1260125-g001.tif"/>
</fig>
<sec id="s2a1"><label>2.1.1</label><title>Pre- and perioperative care of donor and recipient mice</title>
<p>For both procedures (sleeve and cuff), the donor and recipient mice underwent the same pre- and perioperative care as follows. The mice were injected with buprenorphine (0.1 mg/kg, Bupr&#x00E9;care, Centravet, &#x0023;GTIN 03760087151893) and a cocktail of ketamine (50&#x2005;mg/kg) (KETAMINE 1000, Virbac France, &#x0023;03597132111010) and xylazine (10 mg/kg) (Rompun 2&#x0025;, Centravet, &#x0023;ROM001) 15&#x2005;min before the start of the operation. In addition, they were maintained under gas anesthesia throughout the operation (isoflurane 0.5&#x0025;&#x2013;1.5&#x0025;, O<sub>2</sub> rate 0.2&#x2005;L/min) (Vetflurane, Virbac France, VNR 137317; vaporizer: Medical Supplies and Services Int. Ltd., TemSega). The mice underwent the surgery on a heating pad (30&#x2009;&#x00B0;C) and were covered with parafilm to prevent heat loss.</p>
</sec>
<sec id="s2a2"><label>2.1.2</label><title>Sleeve anastomosis procedure</title>
<sec id="s2a2a"><label>2.1.2.1</label><title>Aortic graft preparation from donor mice</title>
<p>Donor mice underwent a laparotomy. The internal organs covering the abdominal aorta (intestinal tract and genital organs) were retracted using a cotton swab and covered with saline-soaked gauze. The aorta was carefully dissociated from the inferior vena cava from the iliac to the mesenteric artery using fine forceps. All collaterals were ligated with 10-0 sutures and cut off. The 10-0 sutures used throughout the protocol were ETHILON &#x0023;FG2850 (Johnson &#x0026; Johnson). Once the abdominal aorta was exposed, the mouse underwent an intracardiac perfusion with heparinated phosphate buffered solution (PBS) and the aorta was harvested and kept at 4&#x2009;&#x00B0;C in heparinated PBS until implantation. The donor mouse was euthanized under anesthesia by exsanguination followed by cervical dislocation.</p>
</sec>
<sec id="s2a2b"><label>2.1.2.2</label><title>Implantation of donor aortic grafts into recipient mice using the sleeve anastomosis</title>
<p>Recipient mice underwent a laparotomy. The internal organs covering the abdominal aorta (intestinal tract and genital organs) were retracted using a cotton swab and covered with saline-soaked gauze. The aorta was carefully dissociated from the inferior vena cava from the iliac to slightly below the renal arteries using fine forceps. All collaterals were ligated with 10-0 monofilament sutures and cut off. The blood flow in the aorta was stopped using slipknots of 7-0 silk suture (MERSILK &#x0023;FK803, Johnson &#x0026; Johnson) placed below the renal arteries and above the iliac arteries. The exposed segment was transversally divided in the middle with micro-scissors. Both ends were rinsed with heparinized saline. The graft was placed in orthotopic position with the recipient aorta and the sleeve anastomosis was performed using 11-0 monofilament sutures (ETHILON &#x0023;FG2881, Johnson &#x0026; Johnson), being careful to avoid any torsion. The 7-0 slipknots were opened (first the caudal, followed by the cephalic knot) to restore blood flow. The absence of blood clot formation or bleeding was monitored for 2&#x2005;min. The bowels and genital organs were replaced in the abdominal cavity and the peritoneal membrane and skin were closed using 6-0 sutures.</p>
</sec>
</sec>
<sec id="s2a3"><label>2.1.3</label><title>Aortic transplantation in mice: cuff anastomosis procedure</title>
<sec id="s2a3a"><label>2.1.3.1</label><title>Aortic graft preparation from donor mice</title>
<p>Donor mice underwent a laparotomy. The internal organs covering the abdominal aorta (intestinal tract and genital organs) were retracted using a cotton swab and covered with saline-soaked gauze. The aorta was carefully dissociated from the inferior vena cava from the iliac to slightly below the renal arteries using fine forceps. All collaterals were ligated with 10-0 sutures and cut off. Once the abdominal aorta was exposed, the mouse underwent an intracardiac perfusion with heparinated PBS and the aorta was harvested. The donor mouse was euthanized under anesthesia by exsanguination followed by cervical dislocation. Homemade 24G Teflon cuffs were used (Intraflon2, PTFE 24G, L.17&#x2005;mm&#x2014;diameter 0.7&#x2005;mm, Vygon &#x0023;121.06). Both ends of the graft were pulled through a cuff and turned around to expose the endothelium. The cuffs were secured with two simple knots (10-0 monofilament sutures). The cuffed grafts were kept at 4&#x2009;&#x00B0;C in heparinated PBS until implantation.</p>
</sec>
<sec id="s2a3b"><label>2.1.3.2</label><title>Implantation of donor aortic grafts into recipient mice using the cuff anastomosis</title>
<p>Recipient mice underwent a laparotomy. The internal organs covering the abdominal aorta (intestinal tract and genital organs) were retracted using a cotton swab and covered with saline-soaked gauze. The aorta was carefully dissociated from the inferior vena cava from the iliac to slightly below the renal arteries using fine forceps. All collaterals were ligated with 10-0 monofilament sutures and cut off. The blood flow in the aorta was stopped using slipknots of 7-0 silk suture (MERSILK &#x0023;FK803, Johnson &#x0026; Johnson) placed below the renal arteries and above the iliac arteries. An incision was performed in the middle of the exposed segment using micro-scissors. The vessel was rinsed through the incision with heparinized saline. The graft was placed in an orthotopic position with the recipient aorta and the cuff anastomosis was performed and secured with 10-0 monofilament sutures, being careful to avoid any torsion. The 7-0 slipknots were opened (first the caudal, followed by the cephalic knot) to restore blood flow. The absence of blood clot formation or bleeding was monitored for 2&#x2005;min. The bowels and genital organs were replaced in the abdominal cavity and the peritoneal membrane and skin were closed using 6-0 sutures.</p>
</sec>
</sec>
<sec id="s2a4"><label>2.1.4</label><title>Postoperative care of recipient mice</title>
<p>Postoperatively, the recipient transplanted mice were allowed to recover in a cage placed on a heating pad and connected to O<sub>2</sub> flow (1&#x2005;L/min) until the next morning (12&#x2013;16&#x2005;h). The mice received buprenorphine injections immediately after the operation. All recipients were treated with intraperitoneal injections of cyclosporin A (10&#x2005;mg/kg/day, &#x0023;BML-195, Enzo Life Sciences): first, 1&#x2005;h before transplantation, and then every day after the surgery for 14 days, in order to dampen the onset of acute rejection. The body condition of the mice was evaluated the next day. In case of paralysis of the hindlimbs (&#x003C;10&#x0025;), the mouse was euthanized. The surviving transplanted mice (90&#x0025;) were then monitored every day until euthanasia.</p>
</sec>
</sec>
<sec id="s2b"><label>2.2</label><title>Histology and morphometric analysis of mouse aortic grafts</title>
<p>Euthanasia of the recipient mice was achieved using a double method: overdose of anesthetics combined with exsanguination by intracardiac perfusion of heparinated PBS. The graft was collected, fixed in formol for 12&#x2005;h, then embedded in paraffin. Cross-sections with a thickness of 4&#x2005;&#x03BC;m were performed using a microtome (RM2145, Leica) and put on charged slides (Superfrost, ThermoFisher Scientific). For each vessel, sections were taken every 100&#x2005;&#x03BC;m starting from the cephalic anastomosis until the caudal anastomosis. The obtained 100&#x2005;&#x03BC;m-spaced sections were stained with Masson Trichrome and the slides were digitized using a slide scanner (3DHISTECH) set on brightfield 40&#x00D7; magnification. For each obtained image, areas of the lumen (A<sub>lum</sub>), and areas delimited by the internal and external elastic laminas (A<sub>IEL</sub> and A<sub>EEL</sub>) were measured using the SlideViewer software (3DHISTECH). The area of the neointima was calculated as follows: A<sub>NI</sub>&#x2009;&#x003D;&#x2009;A<sub>IEL</sub>&#x2009;&#x2212;&#x2009;A<sub>lum</sub>; and the area of the media: A<sub>M</sub>&#x2009;&#x003D;&#x2009;A<sub>EEL</sub>&#x2009;&#x2212;&#x2009;A<sub>IEL</sub>. The extent of intimal hyperplasia was expressed as a A<sub>NI</sub>/A<sub>M</sub> ratio in order to normalize the neointimal area.</p>
</sec>
<sec id="s2c"><label>2.3</label><title>Immunofluorescence of murine aortic grafts</title>
<p>Paraffin sections of aortic grafts (see Section 1.2) were deparaffinated by heating the slides at 60&#x2009;&#x00B0;C for 10&#x2005;min, soaking them in successive baths of xylene and ethanol, and then rehydrating them with water. The antigens were unmasked in citrate pH6 buffer using a pressure cooker. After cooling down, the sections were circled with a hydrophobic pen (DAKO). They were rehydrated in PBS, then PBS&#x2009;&#x002B;&#x2009;Tween 0.1&#x0025;. The unspecific binding was blocked by incubating the slides in PBS&#x2009;&#x002B;&#x2009;BSA 3&#x0025;. Then the slides were incubated at 4&#x2009;&#x00B0;C overnight in a humid atmosphere with a solution of the primary antibody diluted in PBS&#x2009;&#x002B;&#x2009;BSA 3&#x0025; [primary antibodies: smooth muscle actin (SMA) rabbit polyclonal antibody, ThermoFisher, &#x0023;12623297, 1:200; anti-mouse CD45 antibody, clone 30-F11, Biolegend &#x0023;103101, 1:100; rabbit anti-CD3 antibody, clone SP7, Zytomed Systems &#x0023;RBK024, 1:100; CD19 monoclonal antibody, clone LC1, ThermoFisher, &#x0023;14-0190-82, 1:100; goat anti-mouse ICAM-1 antibody, clone M-19, Santa-Cruz Biotechnology, &#x0023;sc-1511, 1:100; rabbit anti-mouse von Willebrand Factor (vWF) antibody, DAKO, &#x0023;A0082, 1:100]. The slides were washed twice in PBS&#x2009;&#x002B;&#x2009;Tween 0.1&#x0025; before incubation with secondary antibodies (AF 488 Goat anti rabbit, Life Technologies, &#x0023;A11034, 1:250; AF 555 Goat anti-mouse, Invitrogen, &#x0023;A21452, 1:250; AF 555 Goat anti-rat, Invitrogen, &#x0023;A214334, 1:250). After washing twice with PBS&#x2009;&#x002B;&#x2009;Tween 0.1&#x0025;, the slides were rinsed in distilled water and mounted with the ProLong Gold Antifade Mountant with DNA stain DAPI (ThermoFisher, &#x0023;P36941). The immunofluorescence images were acquired using a confocal microscope (LSM900, Zeiss, TRI-Genotoul Imaging Facility, I2MC, Toulouse) and digitized with the ZEN software (Zeiss). The analysis was performed using ZEN and Fiji software. Smooth muscle cells, hematopoietic cells, T cells, and B cells, respectively, positive for &#x03B1;SMA, CD45, CD3, and CD19, were counted with the cell counter tool of Fiji. Fluorescence intensity measurements of ICAM-1 and vWF immunostaining in the luminal area were performed as follows. The process was implemented as a macro for the software the ImageJ/Fiji with the use of the MorpholibJ plugin (<xref ref-type="bibr" rid="B16">16</xref>). Using this plugin, we first applied a mask on the luminal layer (20 pixels width). Then, the mean intensity of the fluorescence signal (corresponding to ICAM-1 or vWF) was measured inside the mask, resulting in a quantification of the level of ICAM-1 or vWF protein content in the luminal (endothelial) layer.</p>
</sec>
<sec id="s2d"><label>2.4</label><title>Immunohistochemistry of murine aortic grafts</title>
<p>Paraffin sections of aortic grafts (see Section 1.2) were deparaffinated by heating the slides at 60&#x2009;&#x00B0;C for 10&#x2005;min, soaking them in successive baths of xylene and ethanol, and then rehydrating them with water. The antigens were unmasked in citrate pH6 buffer using a pressure cooker. After cooling down, the sections were circled with a hydrophobic pen (DAKO). They were rehydrated in PBS, then PBS&#x2009;&#x002B;&#x2009;Tween 0.1&#x0025;. Endogenous peroxidases were blocked with H<sub>2</sub>O<sub>2</sub> (10&#x2005;min) and the unspecific binding was blocked by incubating the slides in PBS&#x2009;&#x002B;&#x2009;BSA 3&#x0025;. The slides were then incubated at 4&#x2009;&#x00B0;C overnight in a humid atmosphere with the primary antibody diluted in PBS&#x2009;&#x002B;&#x2009;BSA 3&#x0025; (primary antibody: monoclonal rat anti-mouse IP-10 antibody, R&#x0026;D Systems, &#x0023;MAB466, clone 134013, 1:50). The primary antibody was detected using an ImmPRESS HRP goat anti-rat IgG polymer detection kit (Vector Laboratories &#x0023;MP-7404-50) followed by ImmPACT DAB Substrate Kit (Vector Laboratories &#x0023;SK-4105). The images were acquired using a microscope (Leica DM2500) and the IP-10 signal was quantified using H&#x0026;E DAB color deconvolution with Fiji software. Results are expressed as the percentage of positive pixels.</p>
</sec>
<sec id="s2e"><label>2.5</label><title>Quantification of circulating donor-specific antibodies</title>
<p>Blood samples from all mice were collected on the day of euthanasia in blood collection tubes (Sarstedt, &#x0023;41.1395.005). The blood cell-free fraction was collected after centrifugation. For the analysis of donor-specific antibodies (DSA), plasma samples (diluted at 1:500, 1:1,000, and 1:10,000) were incubated for 30&#x2005;min with splenocytes freshly isolated from BALB/C mice or from B6 mice (baseline negative control) and blocked with PBS&#x2009;&#x002B;&#x2009;10&#x0025; fetal bovine serum in order to enable the binding of plasma antibodies directed against BALB/C epitopes. After washing, the antibody-bound splenocytes were incubated with an AF488-conjugated anti-mouse IgG antibody (Invitrogen &#x0023;A1100) and a PE-Vio615 anti-mouse CD19 antibody (Miltenyi Biotech, &#x0023;130-112-042) to exclude the non-specific detection of surface B-cell immunoglobulins. The data were acquired with a flow cytometer (LSRII BD Fortessa) and analyzed with the BD Diva software. The splenocyte-bound antibody levels were expressed as the mean fluorescence intensity (MFI) of AF488 on the population gated on live singlets after excluding CD19&#x002B; B cells. The MFI of B6-bound serum, considered to be an unspecific binding baseline, was subtracted to the MFI of BALB/C-bound serum to express the relative levels of DSA.</p>
</sec>
<sec id="s2f"><label>2.6</label><title>Study approval</title>
<p>The animal protocol for aortic transplantations was approved by the CEA 122 and the French Ministry of High Education and Research (Minist&#x00E8;re de l&#x2019;Enseignement Sup&#x00E9;rieur et de la Recherche) under number &#x0023;28864.</p>
</sec>
<sec id="s2g"><label>2.7</label><title>Statistical analysis</title>
<p>The statistical significance of the data, presented as mean&#x2009;&#x00B1;&#x2009;SEM, was evaluated using non-parametric Mann&#x2013;Whitney <italic>U</italic> tests. Differences were considered statistically significant at <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05.</p>
</sec>
</sec>
<sec id="s3" sec-type="results"><label>3</label><title>Results</title>
<sec id="s3a"><label>3.1</label><title>A progressive transplant vasculopathy develops in murine aortic grafts connected with both sleeve and cuff anastomosis</title>
<p>Aortic transplantation procedures using the cuff and sleeve anastomosis strategies were performed in male mice aged 8&#x2013;12 weeks. A table recapitulating the ischemia times of both surgeries (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>) shows no statistical difference in the total and cold ischemia times between the sleeve and cuff groups but reveals a significantly longer warm ischemia time for the sleeve group. At 1 and 2 months after abdominal aortic transplantation, the aortic grafts were harvested and analyzed by histology (<xref ref-type="fig" rid="F1">Figures&#x00A0;1A,B</xref>). Sections were taken every 100&#x2005;&#x03BC;m starting from the cranial anastomosis and until the caudal anastomosis to provide an analysis of the full length of the graft and eventually identify anastomosis-dependent effects (<xref ref-type="fig" rid="F1">Figure&#x00A0;1B</xref>). In both groups and at both time-points, the aortic graft cross-sections stained with Masson Trichrome displayed a large neointima composed of multiple cell layers and extracellular matrix (<xref ref-type="fig" rid="F1">Figure&#x00A0;1C</xref>). The media appeared partially depleted of cells, indicating an immune reaction against the donor. The adventitia displayed extensive infiltrates of mononuclear cells, oftentimes organized as aggregates, suggesting an organization of immune cells in lymphoid follicles (<xref ref-type="fig" rid="F1">Figure&#x00A0;1C</xref>). As the proximity to the anastomosis may affect the extent of intimal thickening (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>), we separated the graft into three zones for the quantitative analysis: cranial anastomosis; middle; and caudal anastomosis (<xref ref-type="fig" rid="F1">Figures&#x00A0;1B,C</xref>). At 1 month post-transplantation, the proximity to the anastomosis indeed impacted the extent of intimal hyperplasia in the cuff group (cranial vs. middle, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.056; caudal vs. middle, &#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01). At 1 month post-transplantation, the extent of TV, expressed as the neointima/media ratio, was significantly higher in the sleeve vs. the cuff group in the cranial and middle areas (&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, Mann&#x2013;Whitney <italic>U</italic> test) (<xref ref-type="fig" rid="F1">Figure&#x00A0;1C</xref>), reflected by significant differences in the lumen and neointima in the middle portions (<xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>). At 2 months, the neointima/media ratio was significantly higher in the sleeve vs. the cuff group in the cranial anastomosis portion (&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, Mann&#x2013;Whitney <italic>U</italic> test) (<xref ref-type="fig" rid="F1">Figure&#x00A0;1C</xref>, <xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>). There were no major time-dependent effects of the average neointima/media ratio. The difference between 1 and 2 months in the cuff group was more noticeable than in the sleeve group (<italic>p</italic>&#x2009;&#x003D;&#x2009;0.056), suggesting that the development of TV in the cuff group was more progressive than in the sleeve group (<xref ref-type="fig" rid="F1">Figure&#x00A0;1D</xref>).</p>
<table-wrap id="T1" position="float"><label>Table 1</label>
<caption><p>Ischemia times for murine aortic transplantation surgeries using either cuff or sleeve anastomosis.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left"/>
<th valign="top" align="center">Cuff anastomosis</th>
<th valign="top" align="center">Sleeve anastomosis</th>
<th valign="top" align="center"/>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Total ischemia time (min&#x2009;&#x00B1;&#x2009;SEM)</td>
<td valign="top" align="center">22.89&#x2009;&#x00B1;&#x2009;4.02</td>
<td valign="top" align="center">28.60&#x2009;&#x00B1;&#x2009;1.12</td>
<td valign="top" align="center"><italic>p</italic>&#x2009;&#x003D;&#x2009;0.1019</td>
</tr>
<tr>
<td valign="top" align="left">Cold ischemia time (min&#x2009;&#x00B1;&#x2009;SEM)</td>
<td valign="top" align="center">12.56&#x2009;&#x00B1;&#x2009;10.56</td>
<td valign="top" align="center">5.00&#x2009;&#x00B1;&#x2009;0.00</td>
<td valign="top" align="center"><italic>p</italic>&#x2009;&#x003D;&#x2009;0.1029</td>
</tr>
<tr>
<td valign="top" align="left">Warm ischemia time (min&#x2009;&#x00B1;&#x2009;SEM)</td>
<td valign="top" align="center">10.33&#x2009;&#x00B1;&#x2009;1.236</td>
<td valign="top" align="center">23.60&#x2009;&#x00B1;&#x2009;1.122</td>
<td valign="top" align="center"><italic>p</italic>&#x2009;&#x003D;&#x2009;0.0005&#x002A;&#x002A;&#x002A;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001, Mann-Whitney test.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3b"><label>3.2</label><title>Neointimal VSMCs vs. hematopoietic cells in sleeve and cuff murine aortic grafts</title>
<p>To interrogate potential differences in the cellular composition of the grafts between the sleeve and cuff group, we performed a quantitative analysis of immunofluorescently stained aortic grafts.</p>
<p>We quantified VSMCs and hematopoietic cells inside the neointima based on their positivity for &#x03B1;SMA and CD45, respectively (<xref ref-type="fig" rid="F2">Figure&#x00A0;2A</xref>). The numbers of neointimal &#x03B1;SMA-positive VSMCs, normalized to total neointimal cells (DAPI&#x002B;), were higher on average in the cuff group vs. the sleeve group, as they represented 66&#x0025; vs. 60&#x0025; at 1 month, and 80&#x0025; vs. 64&#x0025; at 2 months, respectively (<xref ref-type="fig" rid="F2">Figure&#x00A0;2B</xref>).</p>
<fig id="F2" position="float"><label>Figure 2</label>
<caption><p>Impact of the sleeve and cuff anastomosis methods on the cellular composition of the neointima in aortic grafts. C57BL/6J recipient mice were orthotopically transplanted with abdominal aortas from BALB/C donor mice, using either the sleeve or the cuff anastomosis method and were analyzed at 1 and 2 months after transplantation (1 month: sleeve group <italic>n</italic>&#x2009;&#x003D;&#x2009;5, cuff group <italic>n</italic>&#x2009;&#x003D;&#x2009;5; 2 months: sleeve group, <italic>n</italic>&#x2009;&#x003D;&#x2009;5; cuff group: <italic>n</italic>&#x2009;&#x003D;&#x2009;5). (<bold>A</bold>) Representative immunofluorescence staining of aortic grafts of indicated groups and time-points. <italic>&#x03B1;</italic>SMA&#x002B; VSMCs appear in green, CD45&#x002B; hematopoietic cells in red and DAPI-stained nuclei in blue. The neointima is delimited in yellow. Scale bar&#x2009;&#x003D;&#x2009;100&#x2005;&#x00B5;m. (<bold>B</bold>) Distribution of <italic>&#x03B1;</italic>SMA&#x002B; VSMCs and CD45&#x002B; hematopoietic cells within the neointima normalized by the total number of cells in indicated mice and time-points. (<bold>C</bold>) Quantification of <italic>&#x03B1;</italic>SMA&#x002B;, CD45&#x2009;&#x002B;&#x2009;and <italic>&#x03B1;</italic>SMA&#x2212;CD45&#x2212; cells within the neointima normalized by the neointimal area in indicated mice. Data are represented as mean&#x2009;&#x00B1;&#x2009;SEM and compared with Mann&#x2013;Whitney tests. &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="frtra-03-1260125-g002.tif"/>
</fig>
<p>The distribution of neointimal VSMCs was different between the two groups: VSMCs populated the luminal layers of the neointima in the sleeve model, while they were evenly distributed throughout the whole neointimal layer in the cuff model (<xref ref-type="fig" rid="F2">Figure&#x00A0;2A</xref>). To summarize this observation, we normalized the VSMC numbers to the neointimal area. The resulting neointimal VSMC coverage was significantly higher in the cuff group vs. the sleeve group at 2 months post-transplantation (&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, Mann&#x2013;Whitney <italic>U</italic> test) (<xref ref-type="fig" rid="F2">Figure&#x00A0;2C</xref>). There were no major differences in either the CD45&#x002B; hematopoietic cells infiltrated within the neointima or in the numbers of &#x03B1;SMA-negative and CD45-negative cells between the cuff and sleeve groups (<xref ref-type="fig" rid="F2">Figures&#x00A0;2B,C</xref>). No differences were observed when the various cell subsets were normalized to total DAPI&#x002B; cells, meaning that the difference observed came from the distribution of VSMCs throughout the neointimal area and not their overall proportion (<xref ref-type="sec" rid="s10">Supplementary Figure S2</xref>).</p>
<p>These data indicate that the type of anastomosis is sufficient to impact the cellular composition and distribution inside the neointima during TV.</p>
</sec>
<sec id="s3c"><label>3.3</label><title>T- and B-cell infiltration differ in sleeve and cuff murine aortic grafts</title>
<p>TV, as a hallmark of chronic rejection, is characterized by the activation of the adaptive immune system against the graft. To explore the effect of the anastomosis on the types of lymphocytes found <italic>in situ</italic>, we quantified CD3&#x002B; T cells and CD19&#x002B; B cells on cross-sections of aortic grafts.</p>
<p>T cells were observed in all three layers (neointima, media, adventitia) in grafts from both groups (<xref ref-type="fig" rid="F3">Figure&#x00A0;3A</xref>). No major differences were observed in the total T-cell content per section, in the neointima or in the media in the cuff vs. the sleeve models at 1 month after transplantation (<xref ref-type="fig" rid="F3">Figure&#x00A0;3B</xref>). At 2 months, however, higher numbers of T cells infiltrated the neointima in the sleeve group compared to the cuff group (&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, Mann&#x2013;Whitney <italic>U</italic> test) (<xref ref-type="fig" rid="F3">Figure&#x00A0;3B</xref>).</p>
<fig id="F3" position="float"><label>Figure 3</label>
<caption><p>Impact of the sleeve and cuff anastomosis methods on T-cell infiltration of aortic grafts. C57BL/6J recipient mice were orthotopically transplanted with abdominal aortas from BALB/C donor mice, using either the sleeve or the cuff anastomosis method and were analyzed at 1 and 2 months after transplantation (1 month: sleeve group <italic>n</italic>&#x2009;&#x003D;&#x2009;5, cuff group <italic>n</italic>&#x2009;&#x003D;&#x2009;5; 2 months: sleeve group, <italic>n</italic>&#x2009;&#x003D;&#x2009;5; cuff group: <italic>n</italic>&#x2009;&#x003D;&#x2009;5). (<bold>A</bold>) Representative immunofluorescence staining of aortic grafts of indicated groups and time-points. CD3&#x002B; T cells appear in green and DAPI-stained nuclei in blue. The neointima is delimited in yellow. Scale bar&#x2009;&#x003D;&#x2009;100&#x2005;&#x00B5;m. (<bold>B</bold>) T-cell content at 1 and 2 months within the total vessel section, neointima (NI) and media, normalized by the area of each zone in indicated mice. Data are represented as mean&#x2009;&#x00B1;&#x2009;SEM and compared with Mann&#x2013;Whitney tests. &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="frtra-03-1260125-g003.tif"/>
</fig>
<p>B cells were found in the adventitia in all groups (<xref ref-type="fig" rid="F4">Figure&#x00A0;4A</xref>). They were either clustered together and intertwined with T cells, suggesting lymphoid aggregates, or disseminated along the external elastic lamina. This differential organization and variations in B-cell morphology (small round cells with a low cytosol/nucleus ratio inside the aggregates; larger cells with a higher cytosol/nucleus ratio in the disseminates fraction) suggest the coexistence of B-cell subpopulations inside the graft (as shown in <xref ref-type="fig" rid="F4">Figure 4A</xref>, in the high magnification for the cuff group at 2 months). Unlike T cells, B cells were not observed in the neointima and the media (<xref ref-type="fig" rid="F4">Figure&#x00A0;4A</xref>). Intriguingly, infiltrating B-cell numbers were significantly higher in the cuff group compared to the sleeve group at 2 months post-transplantation (&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, Mann&#x2013;Whitney <italic>U</italic> test) (<xref ref-type="fig" rid="F4">Figure&#x00A0;4B</xref>). The differences observed in the B-cell numbers were not reflected by the quantification of systemic DSAs, whose levels did not show any significant differences between the sleeve and the cuff group (<xref ref-type="sec" rid="s10">Supplementary Figure S3</xref>), suggesting and uncoupling between local intra-graft B cells and circulating antibodies.</p>
<fig id="F4" position="float"><label>Figure 4</label>
<caption><p>Impact of the sleeve and cuff anastomosis methods on B-cell infiltration of aortic grafts. C57BL/6J recipient mice were orthotopically transplanted with abdominal aortas from BALB/C donor mice, using either the sleeve or the cuff anastomosis method and were analyzed at 1 and 2 months after transplantation (1 month: sleeve group, <italic>n</italic>&#x2009;&#x003D;&#x2009;5; cuff group, <italic>n</italic>&#x2009;&#x003D;&#x2009;5; 2 months: sleeve group, <italic>n</italic>&#x2009;&#x003D;&#x2009;5; cuff group, <italic>n</italic>&#x2009;&#x003D;&#x2009;5). (<bold>A</bold>) Representative immunofluorescence staining of aortic grafts of indicated groups and time-points. CD19&#x002B; B-cells appear in green and DAPI-stained nuclei in blue. The neointima is delimited in yellow. Scale bar&#x2009;&#x003D;&#x2009;100&#x2005;&#x00B5;m. (<bold>B</bold>) B-cell content at 1 and 2 months within total vessel, normalized to the total area of the vessel in indicated mice. Data are represented as mean&#x2009;&#x00B1;&#x2009;SEM and compared with Mann&#x2013;Whitney tests. &#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="frtra-03-1260125-g004.tif"/>
</fig>
<p>To better understand the processes underlying the differences observed between the two methods, we performed an immunofluorescence analysis of two markers of endothelial activation (ICAM-1, vWF) and an immunohistochemical analysis of the chemokine IP-10 (interferon-gamma-inducible protein 10&#x2005;kDa), associated with graft rejection in patients, in particular antibody-mediated rejection (ABMR). At 1 month after aortic transplantation, the endothelial activation marker abundance in the endothelial layer was unchanged between the two methods (<xref ref-type="sec" rid="s10">Supplementary Figure S4</xref>), while, interestingly, IP-10 abundance within the grafts was significantly higher when using the cuff vs. sleeve anastomosis (&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, Mann&#x2013;Whitney <italic>U</italic> test) (<xref ref-type="fig" rid="F5">Figure&#x00A0;5</xref>).</p>
<fig id="F5" position="float"><label>Figure 5</label>
<caption><p>Impact of the sleeve and cuff anastomosis methods on local IP-10 abundance in aortic grafts. C57BL/6J recipient mice were orthotopically transplanted with abdominal aortas from BALB/C donor mice, using either the sleeve or the cuff anastomosis method and were analyzed at 1 month after transplantation (1 month: sleeve group <italic>n</italic>&#x2009;&#x003D;&#x2009;5, cuff group <italic>n</italic>&#x2009;&#x003D;&#x2009;5). (<bold>A</bold>) Representative immunohistochemical staining images (and zoomed areas) for chemokine IP-10 of aortic grafts of indicated groups and time-points. Scale bar&#x2009;&#x003D;&#x2009;100&#x2005;&#x00B5;m. (<bold>B</bold>) CXCL10 content is expressed as &#x0025; of positive pixels/section (brown signal) of indicated mice. Data are represented as mean&#x2009;&#x00B1;&#x2009;SEM and compared with a Mann&#x2013;Whitney test. &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="frtra-03-1260125-g005.tif"/>
</fig>
<p>Overall, our data uncovered a prominent effect of the type of anastomosis on the local immune profile of aortic grafts, associated with a differential content of the chemokine IP-10.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion"><label>4</label><title>Discussion</title>
<p>In this study, we investigated how the type of anastomosis used for aortic transplantation in mice impacts the determinants of TV. While the type of anastomosis did not affect the overall histological features of TV, it deeply impacted the cellular landscape of aortic grafts.</p>
<p>We chose to compare the sleeve and the cuff anastomosis because in our experience both techniques are time-saving compared to the end-to-end anastomosis. Moreover, the sleeve anastomosis only involves one stitch, generating less trauma than the multiple stitches necessary to secure an end-to-end anastomosis. We used a BALB&#x2013;B6 donor&#x2013;recipient combination, as it is widely reported in the literature (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Choosing B6 as recipients presents the advantage of this strain being biased toward a Th1 response (<xref ref-type="bibr" rid="B20">20</xref>&#x2013;<xref ref-type="bibr" rid="B22">22</xref>), typically associated with rejection in human transplant recipients (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B23">23</xref>). Other mouse strain combinations are also found in the literature, such as male into female (<xref ref-type="bibr" rid="B24">24</xref>) or B6 into BALB, likely leading to different immune and inflammatory processes. To counteract the acute rejection due to a full major histocompatibility complex (MHC) mismatch between the two strains, and in an attempt to mimic the clinical situation, all recipient mice in our study were treated with a suboptimal dose of cyclosporin A to achieve immunosuppression during the first stages after transplantation (<xref ref-type="bibr" rid="B25">25</xref>). Oftentimes, no immunosuppression is used, likely increasing the severity of the trauma inflicted to the transplanted vessel wall (<xref ref-type="bibr" rid="B26">26</xref>). We transplanted abdominal aortas orthotopically to limit the bias due to altered blood flow. Both abdominal and thoracic aortas are used as donor tissue (<xref ref-type="bibr" rid="B27">27</xref>). Some groups use orthotopic transplantation and others connect the donor aorta to the carotid artery (<xref ref-type="bibr" rid="B13">13</xref>), submitting the vessel to a different hemodynamic constraint.</p>
<p>The detailed morphometric analysis of the aortic grafts, performed on multiple sections of each vessel, uncovered a more pronounced thickening of the vessel wall in the areas adjacent to the anastomosis at 1 month post-transplantation in the cuff group. This anastomosis effect on TV development is likely due to the severity of the trauma undergone by the vessel wall in the connecting areas (surgical manipulation, local changes in blood flow). In line with our data, Ni et al. show that the cellular processes underlying the formation of the neointima depend on the distance to anastomosis in a model of aortic transplantation into the carotid artery in mice (<xref ref-type="bibr" rid="B13">13</xref>).</p>
<p>VSMCs, identified by their positivity for &#x03B1;SMA, were the major cellular component of the neointima in both the cuff and sleeve groups. The higher VSMC coverage observed in the cuff vs. the sleeve group reveals the influence of the anastomotic method on the structure of the neointima. The percentages of VSMCs found in the cuff group clearly exceed those quantified after aorta-into-carotid transplantation in BALB to B6 mice without immunosuppression, suggesting that the trauma in this latter model leads to a more inflammatory neointima rich in recruited cells (<xref ref-type="bibr" rid="B19">19</xref>). Hematopoietic cells infiltrated the neointima in both groups, consistently with other studies (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B28">28</xref>). It is still unclear, however, whether recruited cells contribute to VSMC coverage through differentiation or indirectly by releasing soluble mediators. While our study clearly highlights the quantitative predominance of VSMCs in the rejected vascular wall, little attention has so far been paid to their functions other than structural in TV development, as immune cells retained most of the focus. The high plasticity of VSMCs and their contribution to numerous vascular complications position them as an interesting candidate for further investigations in the context of TV. Besides VSMCs and hematopoietic cells, &#x03B1;SMA-CD45- cells were found in the neointima for the major part in the sleeve group. While we did not investigate the identity of these cells, we can hypothesize an endothelial or adventitial origin (<xref ref-type="bibr" rid="B14">14</xref>). Although the neointimal layer in human TV is commonly accepted as mainly composed of VSMCs, quantitative data specifying their proportion are unavailable. A study suggests that VSMCs are mostly observed in deeper layers of the neointima in human cardiac allograft vasculopathy (<xref ref-type="bibr" rid="B11">11</xref>), while the luminal layers contain mononuclear cells likely recruited from the circulation.</p>
<p>Our study was designed to provide a quantitative profile of VSMCs depending on the two different anastomosis types we used. Our methodology, however, does not enable us to draw any conclusion regarding the origins of neointimal VSMCs in TV, which has been a long-lasting debate. Both donor and recipient origins have been suggested for neointimal VSMCs in both mice and patients (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>). The progenitors of neointimal VSMCs appear diverse and context-dependent: different studies suggest hematopoietic, adventitial, or medial origins (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B30">30</xref>). Double reporter lineage tracing studies, already available in other contexts such as atherosclerosis or injury-induced restenosis but not TV, are necessary to put an end to this debate.</p>
<p>According to our data, the sleeve method is associated with a higher local T-cell content in aortic grafts than the cuff method, while the cuff model is distinguished by a more prominent accumulation of B cells at the later time-point. These results suggest that the two methods are not interchangeable and that their choice depends on the scientific question asked in each particular study. Transplant rejection historically relied on a T-cell-centric paradigm. As a consequence of the failure of T-cell-targeting therapies in significantly improving long-term outcomes after organ transplantation, B cells arose as key players in the context of chronic rejection over the recent years (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). B cells are thought to participate to graft rejection through several mechanisms. Donor-specific antibodies produced by differentiated B cells are a major risk factor for chronic rejection, particularly for TV (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B34">34</xref>). Besides alloreactive B cells, autoreactive and polyreactive B-cell infiltrates are found in the adventitia of arteries with TV in cardiac allografts, suggesting a role for autoantibodies in transplant rejection (<xref ref-type="bibr" rid="B9">9</xref>). Interestingly, CD19&#x002B; B cells are specifically associated with arteries, in kidney allograft biopsies, independently on the rejection phenotype, as recently shown using spatial transcriptomics (<xref ref-type="bibr" rid="B35">35</xref>). Antibody-independent functions have also been highlighted, as B cells can provide help to alloreactive T cells (<xref ref-type="bibr" rid="B36">36</xref>) or could participate in maintaining an inflammatory milieu within the graft (<xref ref-type="bibr" rid="B37">37</xref>). Under some circumstances, B cells and antibodies are in contrast able to contribute to graft accommodation or tolerance (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B39">39</xref>). The precise functions of B cells in transplant rejection are still under investigation. While the adaptive B-cell response is classically described in secondary lymphoid organs, multiple recent studies highlight the importance of graft-residing B cells in organ rejection after transplantation (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B40">40</xref>). Graft-infiltrating B cells likely differ from their systemic counterparts by their phenotype and antibody repertoire (<xref ref-type="bibr" rid="B37">37</xref>), which can explain our seemingly controversial observation that while the B-cell content is higher in the cuff method graft, circulating DSA appear similar to the sleeve method. In the lung, local intra-graft B cells are responsible for ABMR (<xref ref-type="bibr" rid="B40">40</xref>). In general, the relative contribution of local vs. systemic B cells to graft rejection remains to be elucidated. The cuff model seems like an interesting option to investigate the role of local intra-graft B cells in rejection.</p>
<p>The different immune cell recruitment profiles observed between the two anastomosis methods could be explained by different blood flow patterns and warm ischemia times, respectively, induced by the cuff and sleeve anastomosis, which are likely to affect the behavior of endothelial cells (<xref ref-type="bibr" rid="B31">31</xref>) and subsequently immune cell infiltration kinetics. To address this possibility, we performed immunofluorescence staining for the adhesion molecule ICAM-1 and vWF, both reported as upregulated on the endothelium in contexts of inflammation (<xref ref-type="bibr" rid="B41">41</xref>&#x2013;<xref ref-type="bibr" rid="B43">43</xref>). The lack of statistically significant difference in ICAM-1 and vWF content between the cuff and the sleeve group at 1 month post-transplantation (<xref ref-type="sec" rid="s10">Supplementary Figure S4</xref>) suggests that the two methods impacted endothelial activation in similar ways.</p>
<p>To assess differences in cytokine/chemokine production between the two models, we performed immunostainings for the chemokine interferon-gamma-induced protein 10&#x2005;kDa (IP-10, also known as CXCL10). Indeed, IP-10 is particularly interesting in the context of transplantation, because its increased levels are a common feature of the rejection of multiple transplanted organs in patients (heart (<xref ref-type="bibr" rid="B44">44</xref>), kidney (<xref ref-type="bibr" rid="B45">45</xref>), lung (<xref ref-type="bibr" rid="B46">46</xref>)), and this chemokine is heavily involved in vascular pathologies (<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>), suggesting that it could play a role in TV development. There moreover seems to be a preferential association between IP-10 and the ABMR phenotype. Indeed, in the kidney transplantation context, the urinary IP-10:creatinine ratio improves the non-invasive diagnosis of ABMR and, when elevated, is associated with death-censored graft loss after ABMR (<xref ref-type="bibr" rid="B45">45</xref>). Finally, a group of transcripts including CXCL10 discriminates patients with ABMR after heart transplantation (<xref ref-type="bibr" rid="B44">44</xref>). Interestingly, a significantly higher IP-10 abundance was found in mouse aortic allografts in the cuff vs. the sleeve anastomosis group. This finding suggests that the cuff method is more suitable to mimic human transplant rejection, particularly ABMR, additionally characterized in the cuff group by a higher intra-graft B-cell infiltration compared with the sleeve group. The increase in IP-10 expression classically relies on the presence of interferon-gamma (<xref ref-type="bibr" rid="B49">49</xref>), suggesting that the immune response in the cuff model is Th1-driven.</p>
<p>Mouse models of aortic transplantation are not standardized. We highlight the deep impact of a minor modification of the experimental protocol on the outcomes of the graft and the underlying mechanisms, stressing the need to thoroughly characterize mouse models to estimate their relative suitability to address specific clinical questions.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability"><title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6" sec-type="ethics-statement"><title>Ethics statement</title>
<p>The animal study was approved by CEA 112 Comit&#x00E9; d&#x2019;Ethique de l&#x2019;US 006/CREFRE. The study was conducted in accordance with the national legislation and institutional requirements.</p>
</sec>
<sec id="s7" sec-type="author-contributions"><title>Author contributions</title>
<p>LM: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. RZ: Methodology, Writing &#x2013; original draft. KC: Data curation, Writing &#x2013; review &#x0026; editing. SP: Resources, Writing &#x2013; original draft. AD: Investigation, Resources, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. ML: Conceptualization, Funding acquisition, Investigation, Supervision, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. NS: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec id="s8" sec-type="funding-information"><title>Funding</title>
<p>The authors declare that financial support was received for the research, authorship, and/or publication of this article.</p>
<p>This study was supported by funding from Agence Nationale de la Recherche (ANR-22-CD14-0012), Fondation pour la Recherche M&#x00E9;dicale (PME202106013863) and INSERM.</p>
</sec>
<ack><title>Acknowledgments</title>
<p>We acknowledge Ma&#x00EB;va Fressinaud for her technical assistance with this project. We would also like to thank zootechnie of Rangueil, CREFRE, INSERM US006, the Imaging Facility of the I2MC, Toulouse (TRI-Genotoul) and the Histopathology Facility (CREFRE, INSERM, Toulouse).</p>
</ack>
<sec id="s9" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>Authors NS and ADB declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="s11" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s10" sec-type="supplementary-material"><title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/frtra.2024.1260125/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/frtra.2024.1260125/full&#x0023;supplementary-material</ext-link></p>
<supplementary-material id="SD1" content-type="local-data">
<media mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="Datasheet1.docx"/></supplementary-material>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr" id="fn001"><p>TV, transplant vasculopathy; VSMC, vascular smooth muscle cells; SMA, smooth muscle actin; B6, C57BL/6J; MHC, major histocompatibility complex; DSA, donor-specific antibody.</p></fn>
</fn-group>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname><given-names>DC</given-names></name><name><surname>Perch</surname><given-names>M</given-names></name><name><surname>Zuckermann</surname><given-names>A</given-names></name><name><surname>Cherikh</surname><given-names>WS</given-names></name><name><surname>Harhay</surname><given-names>MO</given-names></name><name><surname>Hayes</surname><given-names>D</given-names><suffix>Jr</suffix></name><etal/></person-group> <article-title>The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-eighth adult lung transplantation report&#x2014;2021; focus on recipient characteristics</article-title>. <source>J Heart Lung Transplant</source>. (<year>2021</year>) <volume>40</volume>(<issue>10</issue>):<fpage>1060</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.healun.2021.07.021</pub-id><pub-id pub-id-type="pmid">34446355</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schinstock</surname><given-names>CA</given-names></name><name><surname>Mannon</surname><given-names>RB</given-names></name><name><surname>Budde</surname><given-names>K</given-names></name><name><surname>Chong</surname><given-names>AS</given-names></name><name><surname>Haas</surname><given-names>M</given-names></name><name><surname>Knechtle</surname><given-names>S</given-names></name><etal/></person-group> <article-title>Recommended treatment for antibody-mediated rejection after kidney transplantation: the 2019 expert consensus from the transplantion society working group</article-title>. <source>Transplantation</source>. (<year>2020</year>) <volume>104</volume>(<issue>5</issue>):<fpage>911</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1097/TP.0000000000003095</pub-id><pub-id pub-id-type="pmid">31895348</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roufosse</surname><given-names>C</given-names></name><name><surname>Simmonds</surname><given-names>N</given-names></name><name><surname>Clahsen-van Groningen</surname><given-names>M</given-names></name><name><surname>Haas</surname><given-names>M</given-names></name><name><surname>Henriksen</surname><given-names>KJ</given-names></name><name><surname>Horsfield</surname><given-names>C</given-names></name><etal/></person-group> <article-title>A 2018 reference guide to the Banff classification of renal allograft pathology</article-title>. <source>Transplantation</source>. (<year>2018</year>) <volume>102</volume>(<issue>11</issue>):<fpage>1795</fpage>&#x2013;<lpage>814</lpage>. <pub-id pub-id-type="doi">10.1097/TP.0000000000002366</pub-id><pub-id pub-id-type="pmid">30028786</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lefaucheur</surname><given-names>C</given-names></name><name><surname>Loupy</surname><given-names>A</given-names></name></person-group>. <article-title>Antibody-mediated rejection of solid-organ allografts</article-title>. <source>N Engl J Med</source>. (<year>2018</year>) <volume>379</volume>(<issue>26</issue>):<fpage>2580</fpage>&#x2013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMc1813976</pub-id><pub-id pub-id-type="pmid">30586534</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Loupy</surname><given-names>A</given-names></name><name><surname>Vernerey</surname><given-names>D</given-names></name><name><surname>Viglietti</surname><given-names>D</given-names></name><name><surname>Aubert</surname><given-names>O</given-names></name><name><surname>Duong Van Huyen</surname><given-names>JP</given-names></name><name><surname>Empana</surname><given-names>JP</given-names></name><etal/></person-group> <article-title>Determinants and outcomes of accelerated arteriosclerosis: major impact of circulating antibodies</article-title>. <source>Circ Res</source>. (<year>2015</year>) <volume>117</volume>(<issue>5</issue>):<fpage>470</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.306340</pub-id><pub-id pub-id-type="pmid">26056252</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>N</given-names></name></person-group>. <article-title>Vascular rejection in cardiac allograft vasculopathy: impact on graft survival</article-title>. <source>Front Cardiovasc Med</source>. (<year>2022</year>) <volume>9</volume>:<fpage>919036</fpage>. <pub-id pub-id-type="doi">10.3389/fcvm.2022.919036</pub-id><pub-id pub-id-type="pmid">35990962</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pober</surname><given-names>JS</given-names></name><name><surname>Chih</surname><given-names>S</given-names></name><name><surname>Kobashigawa</surname><given-names>J</given-names></name><name><surname>Madsen</surname><given-names>JC</given-names></name><name><surname>Tellides</surname><given-names>G</given-names></name></person-group>. <article-title>Cardiac allograft vasculopathy: current review and future research directions</article-title>. <source>Cardiovasc Res</source>. (<year>2021</year>) <volume>117</volume>(<issue>13</issue>):<fpage>2624</fpage>&#x2013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvab259</pub-id><pub-id pub-id-type="pmid">34343276</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chappell</surname><given-names>J</given-names></name><name><surname>Harman</surname><given-names>JL</given-names></name><name><surname>Narasimhan</surname><given-names>VM</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Foote</surname><given-names>K</given-names></name><name><surname>Simons</surname><given-names>BD</given-names></name><etal/></person-group> <article-title>Extensive proliferation of a subset of differentiated, yet plastic, medial vascular smooth muscle cells contributes to neointimal formation in mouse injury and atherosclerosis models</article-title>. <source>Circ Res</source>. (<year>2016</year>) <volume>119</volume>(<issue>12</issue>):<fpage>1313</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.309799</pub-id><pub-id pub-id-type="pmid">27682618</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>D</given-names></name><name><surname>Moore</surname><given-names>C</given-names></name><name><surname>Gao</surname><given-names>B</given-names></name><name><surname>Clerkin</surname><given-names>KJ</given-names></name><name><surname>See</surname><given-names>SB</given-names></name><name><surname>Shaked</surname><given-names>D</given-names></name><etal/></person-group> <article-title>Prevalence of polyreactive innate clones among graft&#x2013;infiltrating B cells in human cardiac allograft vasculopathy</article-title>. <source>J Heart Lung Transplant</source>. (<year>2018</year>) <volume>37</volume>(<issue>3</issue>):<fpage>385</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.healun.2017.09.011</pub-id><pub-id pub-id-type="pmid">29055600</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galvani</surname><given-names>S</given-names></name><name><surname>Trayssac</surname><given-names>M</given-names></name><name><surname>Auge</surname><given-names>N</given-names></name><name><surname>Thiers</surname><given-names>JC</given-names></name><name><surname>Calise</surname><given-names>D</given-names></name><name><surname>Krell</surname><given-names>HW</given-names></name><etal/></person-group> <article-title>A key role for matrix metalloproteinases and neutral sphingomyelinase-2 in transplant vasculopathy triggered by anti-HLA antibody</article-title>. <source>Circulation</source>. (<year>2011</year>) <volume>124</volume>(<issue>24</issue>):<fpage>2725</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.021790</pub-id><pub-id pub-id-type="pmid">22082680</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Loosdregt</surname><given-names>J</given-names></name><name><surname>van Oosterhout</surname><given-names>MF</given-names></name><name><surname>Bruggink</surname><given-names>AH</given-names></name><name><surname>van Wichen</surname><given-names>DF</given-names></name><name><surname>van Kuik</surname><given-names>J</given-names></name><name><surname>de Koning</surname><given-names>E</given-names></name><etal/></person-group> <article-title>The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response</article-title>. <source>Circulation</source>. (<year>2006</year>) <volume>114</volume>(<issue>15</issue>):<fpage>1599</fpage>&#x2013;<lpage>607</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.597526</pub-id><pub-id pub-id-type="pmid">17015796</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rowinska</surname><given-names>Z</given-names></name><name><surname>Gorressen</surname><given-names>S</given-names></name><name><surname>Merx</surname><given-names>MW</given-names></name><name><surname>Koeppel</surname><given-names>TA</given-names></name><name><surname>Zernecke</surname><given-names>A</given-names></name><name><surname>Liehn</surname><given-names>EA</given-names></name></person-group>. <article-title>Using the sleeve technique in a mouse model of aortic transplantation&#x2014;an instructional video</article-title>. <source>J Vis Exp</source>. (<year>2017</year>) <volume>128</volume>:<fpage>54915</fpage>. <pub-id pub-id-type="doi">10.3791/54915</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>Z</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Potter</surname><given-names>CMF</given-names></name><name><surname>Nowak</surname><given-names>WN</given-names></name><name><surname>Gu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><etal/></person-group> <article-title>Recipient c-kit lineage cells repopulate smooth muscle cells of transplant arteriosclerosis in mouse models</article-title>. <source>Circ Res</source>. (<year>2019</year>) <volume>125</volume>(<issue>2</issue>):<fpage>223</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.119.314855</pub-id><pub-id pub-id-type="pmid">31079549</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>Arterial Sca1(&#x002B;) vascular stem cells generate de novo smooth muscle for artery repair and regeneration</article-title>. <source>Cell Stem Cell</source>. (<year>2020</year>) <volume>26</volume>(<issue>1</issue>):<fpage>81</fpage>&#x2013;<lpage>96.e4</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2019.11.010</pub-id><pub-id pub-id-type="pmid">31883835</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Cheng</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name></person-group>. <article-title>Sleeve technique is superior to end-to-end anastomosis and cuff technology in mouse model of graft vascular disease</article-title>. <source>Ann Vasc Surg</source>. (<year>2021</year>) <volume>73</volume>:<fpage>438</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.avsg.2021.01.055</pub-id><pub-id pub-id-type="pmid">33539949</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Legland</surname><given-names>D</given-names></name><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><name><surname>Andrey</surname><given-names>P</given-names></name></person-group>. <article-title>Morpholibj: integrated library and plugins for mathematical morphology with ImageJ</article-title>. <source>Bioinformatics</source>. (<year>2016</year>) <volume>32</volume>(<issue>22</issue>):<fpage>3532</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btw413</pub-id><pub-id pub-id-type="pmid">27412086</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hillebrands</surname><given-names>JL</given-names></name><name><surname>Klatter</surname><given-names>FA</given-names></name><name><surname>Rozing</surname><given-names>J</given-names></name></person-group>. <article-title>Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. (<year>2003</year>) <volume>23</volume>(<issue>3</issue>):<fpage>380</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1161/01.ATV.0000059337.60393.64</pub-id><pub-id pub-id-type="pmid">12615698</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bigaud</surname><given-names>M</given-names></name><name><surname>Schraa</surname><given-names>EO</given-names></name><name><surname>Andriambeloson</surname><given-names>E</given-names></name><name><surname>Lobstein</surname><given-names>V</given-names></name><name><surname>Pally</surname><given-names>C</given-names></name><name><surname>Kobel</surname><given-names>T</given-names></name><etal/></person-group> <article-title>Complete loss of functional smooth muscle cells precedes vascular remodeling in rat aorta allografts</article-title>. <source>Transplantation</source>. (<year>1999</year>) <volume>68</volume>(<issue>11</issue>):<fpage>1701</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1097/00007890-199912150-00013</pub-id><pub-id pub-id-type="pmid">10609946</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Gu</surname><given-names>W</given-names></name><name><surname>Ni</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Kamra</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>Impact of local alloimmunity and recipient cells in transplant arteriosclerosis</article-title>. <source>Circ Res</source>. (<year>2020</year>) <volume>127</volume>(<issue>8</issue>):<fpage>974</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.119.316470</pub-id><pub-id pub-id-type="pmid">32689904</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heinzel</surname><given-names>FP</given-names></name><name><surname>Sadick</surname><given-names>MD</given-names></name><name><surname>Holaday</surname><given-names>BJ</given-names></name><name><surname>Coffman</surname><given-names>RL</given-names></name><name><surname>Locksley</surname><given-names>RM</given-names></name></person-group>. <article-title>Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets</article-title>. <source>J Exp Med</source>. (<year>1989</year>) <volume>169</volume>(<issue>1</issue>):<fpage>59</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1084/jem.169.1.59</pub-id><pub-id pub-id-type="pmid">2521244</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fukushima</surname><given-names>A</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name><name><surname>Ishida</surname><given-names>W</given-names></name><name><surname>Fukata</surname><given-names>K</given-names></name><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>FT</given-names></name><etal/></person-group> <article-title>Genetic background determines susceptibility to experimental immune-mediated blepharoconjunctivitis: comparison of Balb/c and C57BL/6 mice</article-title>. <source>Exp Eye Res</source>. (<year>2006</year>) <volume>82</volume>(<issue>2</issue>):<fpage>210</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.exer.2005.06.010</pub-id><pub-id pub-id-type="pmid">16102751</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guler</surname><given-names>ML</given-names></name><name><surname>Gorham</surname><given-names>JD</given-names></name><name><surname>Hsieh</surname><given-names>CS</given-names></name><name><surname>Mackey</surname><given-names>AJ</given-names></name><name><surname>Steen</surname><given-names>RG</given-names></name><name><surname>Dietrich</surname><given-names>WF</given-names></name><etal/></person-group> <article-title>Genetic susceptibility to leishmania: IL-12 responsiveness in TH1 cell development</article-title>. <source>Science</source>. (<year>1996</year>) <volume>271</volume>(<issue>5251</issue>):<fpage>984</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1126/science.271.5251.984</pub-id><pub-id pub-id-type="pmid">8584935</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Habal</surname><given-names>MV</given-names></name><name><surname>Miller</surname><given-names>AMI</given-names></name><name><surname>Rao</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Obradovic</surname><given-names>A</given-names></name><name><surname>Khosravi-Maharlooei</surname><given-names>M</given-names></name><etal/></person-group> <article-title>T cell repertoire analysis suggests a prominent bystander response in human cardiac allograft vasculopathy</article-title>. <source>Am J Transplant</source>. (<year>2021</year>) <volume>21</volume>(<issue>4</issue>):<fpage>1465</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1111/ajt.16333</pub-id><pub-id pub-id-type="pmid">33021057</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ostriker</surname><given-names>AC</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Chakraborty</surname><given-names>R</given-names></name><name><surname>Sizer</surname><given-names>AJ</given-names></name><name><surname>Bai</surname><given-names>Y</given-names></name><name><surname>Ding</surname><given-names>M</given-names></name><etal/></person-group> <article-title>TET2 protects against vascular smooth muscle cell apoptosis and intimal thickening in transplant vasculopathy</article-title>. <source>Circulation</source>. (<year>2021</year>) <volume>144</volume>(<issue>6</issue>):<fpage>455</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.120.050553</pub-id><pub-id pub-id-type="pmid">34111946</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zarjou</surname><given-names>A</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Sanders</surname><given-names>PW</given-names></name><name><surname>Mannon</surname><given-names>RB</given-names></name><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>George</surname><given-names>JF</given-names></name></person-group>. <article-title>A reproducible mouse model of chronic allograft nephropathy with vasculopathy</article-title>. <source>Kidney Int</source>. (<year>2012</year>) <volume>82</volume>(<issue>11</issue>):<fpage>1231</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/ki.2012.277</pub-id><pub-id pub-id-type="pmid">22874842</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Mokhtari</surname><given-names>GK</given-names></name><name><surname>Balsam</surname><given-names>LB</given-names></name><name><surname>Cooke</surname><given-names>DT</given-names></name><name><surname>Kofidis</surname><given-names>T</given-names></name><name><surname>Zwierzchonievska</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model</article-title>. <source>J Heart Lung Transplant</source>. (<year>2005</year>) <volume>24</volume>(<issue>4</issue>):<fpage>446</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.healun.2004.01.022</pub-id><pub-id pub-id-type="pmid">15797747</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dietrich</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Zou</surname><given-names>Y</given-names></name><name><surname>Dirnhofer</surname><given-names>S</given-names></name><name><surname>Kleindienst</surname><given-names>R</given-names></name><name><surname>Wick</surname><given-names>G</given-names></name><etal/></person-group> <article-title>Mouse model of transplant arteriosclerosis: role of intercellular adhesion molecule-1</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. (<year>2000</year>) <volume>20</volume>(<issue>2</issue>):<fpage>343</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1161/01.ATV.20.2.343</pub-id><pub-id pub-id-type="pmid">10669629</pub-id></citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>RN</given-names></name><name><surname>Libby</surname><given-names>P</given-names></name></person-group>. <article-title>Vascular remodeling in transplant vasculopathy</article-title>. <source>Circ Res</source>. (<year>2007</year>) <volume>100</volume>(<issue>7</issue>):<fpage>967</fpage>&#x2013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000261982.76892.09</pub-id><pub-id pub-id-type="pmid">17431198</pub-id></citation></ref>
<ref id="B29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quaini</surname><given-names>F</given-names></name><name><surname>Urbanek</surname><given-names>K</given-names></name><name><surname>Beltrami</surname><given-names>AP</given-names></name><name><surname>Finato</surname><given-names>N</given-names></name><name><surname>Beltrami</surname><given-names>CA</given-names></name><name><surname>Nadal-Ginard</surname><given-names>B</given-names></name><etal/></person-group> <article-title>Chimerism of the transplanted heart</article-title>. <source>N Engl J Med</source>. (<year>2002</year>) <volume>346</volume>(<issue>1</issue>):<fpage>5</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa012081</pub-id><pub-id pub-id-type="pmid">11777997</pub-id></citation></ref>
<ref id="B30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dobnikar</surname><given-names>L</given-names></name><name><surname>Taylor</surname><given-names>AL</given-names></name><name><surname>Chappell</surname><given-names>J</given-names></name><name><surname>Oldach</surname><given-names>P</given-names></name><name><surname>Harman</surname><given-names>JL</given-names></name><name><surname>Oerton</surname><given-names>E</given-names></name><etal/></person-group> <article-title>Disease-relevant transcriptional signatures identified in individual smooth muscle cells from healthy mouse vessels</article-title>. <source>Nat Commun</source>. (<year>2018</year>) <volume>9</volume>(<issue>1</issue>):<fpage>4567</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-018-06891-x</pub-id><pub-id pub-id-type="pmid">30385745</pub-id></citation></ref>
<ref id="B31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nasr</surname><given-names>M</given-names></name><name><surname>Fay</surname><given-names>A</given-names></name><name><surname>Lupieri</surname><given-names>A</given-names></name><name><surname>Malet</surname><given-names>N</given-names></name><name><surname>Darmon</surname><given-names>A</given-names></name><name><surname>Zahreddine</surname><given-names>R</given-names></name><etal/></person-group> <article-title>PI3KCIIalpha-dependent autophagy program protects from endothelial dysfunction and atherosclerosis in response to low shear stress in mice</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. (<year>2024</year>) <volume>44</volume>(<issue>3</issue>):<fpage>620</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.123.319978</pub-id><pub-id pub-id-type="pmid">38152888</pub-id></citation></ref>
<ref id="B32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smirnova</surname><given-names>NF</given-names></name><name><surname>Conlon</surname><given-names>TM,</given-names></name><name><surname>Morrone</surname><given-names>C</given-names></name><name><surname>Dorfmuller</surname><given-names>P</given-names></name><name><surname>Humbert</surname><given-names>M</given-names></name><name><surname>Stathopoulos</surname><given-names>G</given-names></name><etal/></person-group> <article-title>Inhibition of B cell&#x2013;dependent lymphoid follicle formation prevents lymphocytic bronchiolitis after lung transplantation</article-title>. <source>JCI Insight</source>. (<year>2019</year>) <volume>4</volume>(<issue>3</issue>):<fpage>e123971</fpage>. <pub-id pub-id-type="doi">10.1172/jci.insight.123971</pub-id><pub-id pub-id-type="pmid">30728330</pub-id></citation></ref>
<ref id="B33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smirnova</surname><given-names>NF</given-names></name><name><surname>Riemondy</surname><given-names>K</given-names></name><name><surname>Bueno</surname><given-names>M</given-names></name><name><surname>Collins</surname><given-names>S</given-names></name><name><surname>Suresh</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group> <article-title>Single-cell transcriptome mapping identifies a local, innate B cell population driving chronic rejection after lung transplantation</article-title>. <source>JCI Insight</source>. (<year>2022</year>) <volume>7</volume>(<issue>18</issue>):<fpage>e156648</fpage>. <pub-id pub-id-type="doi">10.1172/jci.insight.156648</pub-id><pub-id pub-id-type="pmid">36134664</pub-id></citation></ref>
<ref id="B34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Callemeyn</surname><given-names>J</given-names></name><name><surname>Lamarthee</surname><given-names>B</given-names></name><name><surname>Koenig</surname><given-names>A</given-names></name><name><surname>Koshy</surname><given-names>P</given-names></name><name><surname>Thaunat</surname><given-names>O</given-names></name><name><surname>Naesens</surname><given-names>M</given-names></name></person-group>. <article-title>Allorecognition and the spectrum of kidney transplant rejection</article-title>. <source>Kidney Int</source>. (<year>2022</year>) <volume>101</volume>(<issue>4</issue>):<fpage>692</fpage>&#x2013;<lpage>710</lpage>. <pub-id pub-id-type="doi">10.1016/j.kint.2021.11.029</pub-id><pub-id pub-id-type="pmid">34915041</pub-id></citation></ref>
<ref id="B35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>MP</given-names></name><name><surname>Zaidi</surname><given-names>M</given-names></name><name><surname>Larson</surname><given-names>N</given-names></name><name><surname>Mullan</surname><given-names>A</given-names></name><name><surname>Pavelko</surname><given-names>KD</given-names></name><name><surname>Stegall</surname><given-names>MD</given-names></name><etal/></person-group> <article-title>Exploring the single-cell immune landscape of kidney allograft inflammation using imaging mass cytometry</article-title>. <source>Am J Transplant</source>. (<year>2024</year>) (<issue>4</issue>):<fpage>549</fpage>&#x2013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajt.2023.11.008</pub-id><pub-id pub-id-type="pmid">37979921</pub-id></citation></ref>
<ref id="B36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>Q</given-names></name><name><surname>Ng</surname><given-names>YH</given-names></name><name><surname>Singh</surname><given-names>T</given-names></name><name><surname>Jiang</surname><given-names>K</given-names></name><name><surname>Sheriff</surname><given-names>KA</given-names></name><name><surname>Ippolito</surname><given-names>R</given-names></name><etal/></person-group> <article-title>B cells mediate chronic allograft rejection independently of antibody production</article-title>. <source>J Clin Invest</source>. (<year>2014</year>) <volume>124</volume>(<issue>3</issue>):<fpage>1052</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1172/JCI70084</pub-id><pub-id pub-id-type="pmid">24509079</pub-id></citation></ref>
<ref id="B37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Asano</surname><given-names>Y</given-names></name><name><surname>Daccache</surname><given-names>J</given-names></name><name><surname>Jain</surname><given-names>D</given-names></name><name><surname>Ko</surname><given-names>K</given-names></name><name><surname>Kinloch</surname><given-names>A</given-names></name><name><surname>Veselits</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Innate-like self-reactive B cells infiltrate human renal allografts during transplant rejection</article-title>. <source>Nat Commun</source>. (<year>2021</year>) <volume>12</volume>(<issue>1</issue>):<fpage>4372</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-021-24615-6</pub-id><pub-id pub-id-type="pmid">34272370</pub-id></citation></ref>
<ref id="B38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>R</given-names></name><name><surname>Fitch</surname><given-names>ZW</given-names></name><name><surname>Schroder</surname><given-names>PM</given-names></name><name><surname>Choi</surname><given-names>AY</given-names></name><name><surname>Jackson</surname><given-names>AM</given-names></name><name><surname>Knechtle</surname><given-names>SJ</given-names></name><etal/></person-group> <article-title>B cells in transplant tolerance and rejection: friends or foes?</article-title> <source>Transpl Int</source>. (<year>2020</year>) <volume>33</volume>(<issue>1</issue>):<fpage>30</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1111/tri.13549</pub-id><pub-id pub-id-type="pmid">31705678</pub-id></citation></ref>
<ref id="B39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>AS</given-names></name><name><surname>Sciammas</surname><given-names>R</given-names></name></person-group>. <article-title>Matchmaking the B-cell signature of tolerance to regulatory B cells</article-title>. <source>Am J Transplant</source>. (<year>2011</year>) <volume>11</volume>(<issue>12</issue>):<fpage>2555</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-6143.2011.03773.x</pub-id><pub-id pub-id-type="pmid">21967001</pub-id></citation></ref>
<ref id="B40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Gauthier</surname><given-names>JM</given-names></name><name><surname>Higashikubo</surname><given-names>R</given-names></name><name><surname>Hsiao</surname><given-names>HM</given-names></name><name><surname>Tanaka</surname><given-names>S</given-names></name><name><surname>Vuong</surname><given-names>L</given-names></name><etal/></person-group> <article-title>Bronchus-associated lymphoid tissue-resident Foxp3&#x002B; T lymphocytes prevent antibody-mediated lung rejection</article-title>. <source>J Clin Invest</source>. (<year>2019</year>) <volume>129</volume>(<issue>2</issue>):<fpage>556</fpage>&#x2013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1172/JCI122083</pub-id><pub-id pub-id-type="pmid">30561386</pub-id></citation></ref>
<ref id="B41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kummer</surname><given-names>L</given-names></name><name><surname>Zaradzki</surname><given-names>M</given-names></name><name><surname>Vijayan</surname><given-names>V</given-names></name><name><surname>Arif</surname><given-names>R</given-names></name><name><surname>Weigand</surname><given-names>MA</given-names></name><name><surname>Immenschuh</surname><given-names>S</given-names></name><etal/></person-group> <article-title>Vascular signaling in allogenic solid organ transplantation&#x2014;the role of endothelial cells</article-title>. <source>Front Physiol</source>. (<year>2020</year>) <volume>11</volume>:<fpage>443</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2020.00443</pub-id><pub-id pub-id-type="pmid">32457653</pub-id></citation></ref>
<ref id="B42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manz</surname><given-names>XD</given-names></name><name><surname>Bogaard</surname><given-names>HJ</given-names></name><name><surname>Aman</surname><given-names>J</given-names></name></person-group>. <article-title>Regulation of VWF (von Willebrand factor) in inflammatory thrombosis</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. (<year>2022</year>) <volume>42</volume>(<issue>11</issue>):<fpage>1307</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.122.318179</pub-id><pub-id pub-id-type="pmid">36172866</pub-id></citation></ref>
<ref id="B43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Babkina</surname><given-names>AS</given-names></name><name><surname>Ostrova</surname><given-names>IV</given-names></name><name><surname>Yadgarov</surname><given-names>MY</given-names></name><name><surname>Kuzovlev</surname><given-names>AN</given-names></name><name><surname>Grechko</surname><given-names>AV</given-names></name><name><surname>Volkov</surname><given-names>AV</given-names></name><etal/></person-group> <article-title>The role of von Willebrand factor in the pathogenesis of pulmonary vascular thrombosis in COVID-19</article-title>. <source>Viruses</source>. (<year>2022</year>) <volume>14</volume>(<issue>2</issue>):<fpage>211</fpage>. <pub-id pub-id-type="doi">10.3390/v14020211</pub-id><pub-id pub-id-type="pmid">35215805</pub-id></citation></ref>
<ref id="B44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Loupy</surname><given-names>A</given-names></name><name><surname>Duong Van Huyen</surname><given-names>JP</given-names></name><name><surname>Hidalgo</surname><given-names>L</given-names></name><name><surname>Reeve</surname><given-names>J</given-names></name><name><surname>Racape</surname><given-names>M</given-names></name><name><surname>Aubert</surname><given-names>O</given-names></name><etal/></person-group> <article-title>Gene expression profiling for the identification and classification of antibody-mediated heart rejection</article-title>. <source>Circulation</source>. (<year>2017</year>) <volume>135</volume>(<issue>10</issue>):<fpage>917</fpage>&#x2013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.116.022907</pub-id><pub-id pub-id-type="pmid">28148598</pub-id></citation></ref>
<ref id="B45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rabant</surname><given-names>M</given-names></name><name><surname>Amrouche</surname><given-names>L</given-names></name><name><surname>Lebreton</surname><given-names>X</given-names></name><name><surname>Aulagnon</surname><given-names>F</given-names></name><name><surname>Benon</surname><given-names>A</given-names></name><name><surname>Sauvaget</surname><given-names>V</given-names></name><etal/></person-group> <article-title>Urinary C-X-C motif chemokine 10 independently improves the noninvasive diagnosis of antibody-mediated kidney allograft rejection</article-title>. <source>J Am Soc Nephrol</source>. (<year>2015</year>) <volume>26</volume>(<issue>11</issue>):<fpage>2840</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2014080797</pub-id><pub-id pub-id-type="pmid">25948873</pub-id></citation></ref>
<ref id="B46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shino</surname><given-names>MY</given-names></name><name><surname>Todd</surname><given-names>JL</given-names></name><name><surname>Neely</surname><given-names>ML</given-names></name><name><surname>Kirchner</surname><given-names>J</given-names></name><name><surname>Frankel</surname><given-names>CW</given-names></name><name><surname>Snyder</surname><given-names>LD</given-names></name><etal/></person-group> <article-title>Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction</article-title>. <source>Am J Transplant</source>. (<year>2022</year>) <volume>22</volume>(<issue>9</issue>):<fpage>2169</fpage>&#x2013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1111/ajt.17108</pub-id><pub-id pub-id-type="pmid">35634722</pub-id></citation></ref>
<ref id="B47"><label>47.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smirnova</surname><given-names>NF</given-names></name><name><surname>Gayral</surname><given-names>S</given-names></name><name><surname>Pedros</surname><given-names>C</given-names></name><name><surname>Loirand</surname><given-names>G</given-names></name><name><surname>Vaillant</surname><given-names>N</given-names></name><name><surname>Malet</surname><given-names>N</given-names></name><etal/></person-group> <article-title>Targeting PI3Kgamma activity decreases vascular trauma-induced intimal hyperplasia through modulation of the Th1 response</article-title>. <source>J Exp Med</source>. (<year>2014</year>) <volume>211</volume>(<issue>9</issue>):<fpage>1779</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20131276</pub-id><pub-id pub-id-type="pmid">25073791</pub-id></citation></ref>
<ref id="B48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lupieri</surname><given-names>A</given-names></name><name><surname>Smirnova</surname><given-names>NF</given-names></name><name><surname>Solinhac</surname><given-names>R</given-names></name><name><surname>Malet</surname><given-names>N</given-names></name><name><surname>Benamar</surname><given-names>M</given-names></name><name><surname>Saoudi</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Smooth muscle cells-derived CXCL10 prevents endothelial healing through PI3Kgamma-dependent T cells response</article-title>. <source>Cardiovasc Res</source>. (<year>2020</year>) <volume>116</volume>(<issue>2</issue>):<fpage>438</fpage>&#x2013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvz122</pub-id><pub-id pub-id-type="pmid">31106375</pub-id></citation></ref>
<ref id="B49"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Metzemaekers</surname><given-names>M</given-names></name><name><surname>Vanheule</surname><given-names>V</given-names></name><name><surname>Janssens</surname><given-names>R</given-names></name><name><surname>Struyf</surname><given-names>S</given-names></name><name><surname>Proost</surname><given-names>P</given-names></name></person-group>. <article-title>Overview of the mechanisms that may contribute to the non-redundant activities of interferon-inducible CXC chemokine receptor 3 ligands</article-title>. <source>Front Immunol</source>. (<year>2017</year>) <volume>8</volume>:<fpage>1970</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.01970</pub-id><pub-id pub-id-type="pmid">29379506</pub-id></citation></ref></ref-list>
</back>
</article>